β-Glucuronidase Acts as a Novel Nonantioxidative Target for Vitamin E

Area of Science:

• Biochemistry
• Pharmacology
• Nutritional Science

Background:

• Gut beta-glucuronidase (GUS) deconjugates inactive glucuronides into toxic aglycones in the gastrointestinal tract.
• Inhibiting GUS is crucial for protecting the gut lining from these harmful substances.
• Developing safe and effective GUS inhibitors is a significant area of research.

Purpose of the Study:

• To investigate the potential of natural and synthetic vitamin E (VE) analogues as inhibitors of gut beta-glucuronidase (GUS).
• To determine the inhibitory potency and mechanism of VE analogues against GUS.
• To explore the gastrointestinal protective effects of VE through non-antioxidant pathways.

Main Methods:

• Enzyme inhibition assays were performed to evaluate the potency of VE analogues against GUS.
• Determination of inhibition constants (Ki values) for various VE analogues.
• Molecular docking analysis was employed to elucidate the binding interactions between VE analogues and the GUS active site.

Main Results:

• All tested natural and synthetic VE analogues demonstrated potent inhibition of GUS activity.
• dl-α-tocopherol exhibited the strongest inhibitory effect with a low Ki value of 0.14 μM.
• Docking studies revealed hydrophobic and hydrogen bonding interactions between VE analogues and GUS active site residues.

Conclusions:

• Vitamin E analogues are effective and safe inhibitors of gut beta-glucuronidase (GUS).
• The findings suggest a novel non-antioxidant role for VE in gastrointestinal protection.
• Daily dietary intake of plant foods may contribute to GUS inhibition via VE compounds.